InsiderTrades.com logo
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.

RARE Insider Trading

Insider Ownership Percentage: 5.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $4,701,943.08

Ultragenyx Pharmaceutical Insider Trading History Chart

This chart shows the insider buying and selling history at Ultragenyx Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ultragenyx Pharmaceutical Share Price & Price History

Current Price: $47.24
Price Change: ▲ Price Increase of +1.22 (2.65%)
As of 11/22/2024 01:00 AM ET

This chart shows the closing price history over time for RARE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Financial Prophecy
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Including the name of the #1 company to buy.

Ultragenyx Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/10/2024Howard HornCFOSell7,465$52.76$393,853.4092,301View SEC Filing Icon  
9/3/2024Emil D KakkisCEOSell20,000$55.85$1,117,000.002,223,985View SEC Filing Icon  
9/3/2024Theodore Alan HuizengaCAOSell91$56.19$5,113.2941,551View SEC Filing Icon  
8/6/2024Emil D KakkisCEOSell20,000$50.17$1,003,400.002,243,985View SEC Filing Icon  
7/2/2024Corsee D. SandersDirectorSell584$40.98$23,932.3212,009View SEC Filing Icon  
6/12/2024Karah Herdman ParschauerEVPSell9,806$45.00$441,270.0057,981View SEC Filing Icon  
6/10/2024Corsee D. SandersDirectorSell1,737$41.10$71,390.707,248View SEC Filing Icon  
4/18/2024Eric CrombezEVPSell142$44.10$6,262.2048,785View SEC Filing Icon  
3/11/2024Thomas Richard KassbergEVPSell11,509$49.93$574,644.37252,823View SEC Filing Icon  
3/7/2024Matthew K. FustDirectorSell12,195$50.88$620,481.6014,860View SEC Filing Icon  
3/1/2024John Richard PinionInsiderSell4,173$53.76$224,340.4889,268View SEC Filing Icon  
3/1/2024Karah Herdman ParschauerEVPSell3,756$53.76$201,922.5667,340View SEC Filing Icon  
3/1/2024Theodore Alan HuizengaCAOSell341$53.76$18,332.1641,380View SEC Filing Icon  
10/23/2023Thomas Richard KassbergEVPSell39,878$32.78$1,307,200.84246,860View SEC Filing Icon  
10/19/2023Emil D KakkisCEOSell47,853$33.52$1,604,032.56599,743View SEC Filing Icon  
9/7/2023Theodore Alan HuizengaCAOSell2,163$40.80$88,250.4023,614View SEC Filing Icon  
9/5/2023Erik HarrisEVPSell6,000$37.96$227,760.0051,281View SEC Filing Icon  
9/1/2023Theodore Alan HuizengaCAOSell970$37.15$36,035.5023,777View SEC Filing Icon  
6/30/2023Corsee D. SandersDirectorSell585$46.76$27,354.608,985View SEC Filing Icon  
6/19/2023Erik HarrisEVPSell305$48.20$14,701.0057,281View SEC Filing Icon  
6/8/2023Corsee D. SandersDirectorSell1,485$51.65$76,700.259,570View SEC Filing Icon  
5/18/2023John Richard PinionInsiderSell2,012$50.00$100,600.0074,744View SEC Filing Icon  
5/4/2023Karah Herdman ParschauerEVPSell4,378$45.00$197,010.0051,982View SEC Filing Icon  
3/1/2023Camille L. BedrosianEVPSell3,881$45.25$175,615.2546,720View SEC Filing Icon  
3/1/2023Dennis Karl HuangInsiderSell389$45.65$17,757.8575,314View SEC Filing Icon  
2/28/2023Theodore Alan HuizengaCAOSell639$43.40$27,732.6015,558View SEC Filing Icon  
12/21/2022Theodore Alan HuizengaCAOSell2,031$43.96$89,282.7616,197View SEC Filing Icon  
10/14/2022Mardi DierCFOSell1,629$40.16$65,420.6466,695View SEC Filing Icon  
10/12/2022Mardi DierCFOSell3,484$38.22$133,158.4868,324View SEC Filing Icon  
6/19/2022Erik HarrisEVPSell295$54.78$16,160.1036,160View SEC Filing Icon  
4/16/2022Theodore Alan HuizengaCAOSell132$84.55$11,160.6016,914View SEC Filing Icon  
3/11/2022Thomas Richard KassbergEVPSell10,281$67.01$688,929.81View SEC Filing Icon  
3/7/2022Karah Herdman ParschauerEVPSell5,140$62.95$323,563.00View SEC Filing Icon  
3/1/2022Erik HarrisEVPSell2,713$66.62$180,740.06View SEC Filing Icon  
3/1/2022John Richard PinionInsiderSell4,498$66.62$299,656.76View SEC Filing Icon  
1/30/2022Camille L. BedrosianEVPSell1,657$66.30$109,859.10View SEC Filing Icon  
See Full Table
Trump’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media   |   Ad
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Ultragenyx Pharmaceutical (NASDAQ:RARE)

97.67% of Ultragenyx Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RARE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ultragenyx Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC1,571,081$87.30M0.0%+4.4%1.701%Search for SEC Filing on Google Icon
11/15/2024M&T Bank Corp6,992$0.39M0.0%+8.1%0.008%Search for SEC Filing on Google Icon
11/15/2024Frazier Life Sciences Management L.P.633,715$35.20M1.4%+49.1%0.686%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC79,546$4.42M0.0%-66.4%0.086%Search for SEC Filing on Google Icon
11/15/2024Public Employees Retirement System of Ohio32,734$1.82M0.0%-1.6%0.035%Search for SEC Filing on Google Icon
11/15/2024Nomura Asset Management Co. Ltd.1,669$93K0.0%N/A0.002%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd19,151$1.06M0.1%+193.1%0.021%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd14,629$0.81M0.1%+95.2%0.016%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP4,165,424$231.39M0.0%-8.6%4.511%Search for SEC Filing on Google Icon
11/15/2024Two Sigma Advisers LP987,800$54.87M0.1%+123.4%1.070%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.195,349$10.85M1.7%-33.5%0.212%Search for SEC Filing on Google Icon
11/15/2024State Street Corp2,664,077$147.99M0.0%-1.2%2.885%Search for SEC Filing on Google Icon
11/15/2024Stifel Financial Corp20,961$1.16M0.0%-4.0%0.023%Search for SEC Filing on Google Icon
11/15/2024RTW Investments LP1,968,002$109.32M1.6%-39.6%2.131%Search for SEC Filing on Google Icon
11/15/2024Point72 DIFC Ltd14,517$0.81M0.0%+443.9%0.016%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.653,660$36.31M0.1%+35.9%0.708%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC109,468$6.08M0.8%+9.5%0.119%Search for SEC Filing on Google Icon
11/15/2024Motley Fool Asset Management LLC141,649$8.01M0.5%+0.3%0.153%Search for SEC Filing on Google Icon
11/15/2024Motley Fool Wealth Management LLC168,015$9.33M0.5%-1.4%0.182%Search for SEC Filing on Google Icon
11/15/2024NFJ Investment Group LLC38,131$2.12M0.1%-4.4%0.041%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC179,000$9.94M1.3%N/A0.194%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.97,960$5.44M0.0%-84.6%0.106%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC36,543$2.03M0.0%-49.1%0.040%Search for SEC Filing on Google Icon
11/15/2024Cinctive Capital Management LP15,902$0.88M0.0%-87.4%0.017%Search for SEC Filing on Google Icon
11/15/2024Benjamin Edwards Inc.6,084$0.34M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/15/2024Baker BROS. Advisors LP1,576,114$87.55M0.9%+7.5%1.707%Search for SEC Filing on Google Icon
11/15/2024Bamco Inc. NY48,000$2.67M0.0%N/A0.052%Search for SEC Filing on Google Icon
11/15/2024Point72 Hong Kong Ltd10,020$0.56M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH15,010$0.82M0.0%N/A0.016%Search for SEC Filing on Google Icon
11/15/2024True Wealth Design LLC778$43K0.0%N/A0.001%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC66,193$3.68M0.3%+26.1%0.072%Search for SEC Filing on Google Icon
11/14/2024Fred Alger Management LLC536,298$29.79M0.1%-2.3%0.581%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC77,306$4.29M0.0%-43.7%0.084%Search for SEC Filing on Google Icon
11/14/2024Captrust Financial Advisors11,428$0.64M0.0%+129.3%0.012%Search for SEC Filing on Google Icon
11/14/2024Vestal Point Capital LP750,000$41.66M3.2%-58.3%0.812%Search for SEC Filing on Google Icon
11/14/2024Capstone Investment Advisors LLC13,089$0.73M0.0%N/A0.014%Search for SEC Filing on Google Icon
11/14/2024Suvretta Capital Management LLC1,151,314$63.96M2.0%-44.1%1.247%Search for SEC Filing on Google Icon
11/14/2024Hantz Financial Services Inc.3,499$0.19M0.0%N/A0.004%Search for SEC Filing on Google Icon
11/14/2024Alkeon Capital Management LLC3,011,716$167.30M0.3%+34.3%3.261%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC177,756$9.87M0.0%+0.5%0.192%Search for SEC Filing on Google Icon
11/14/2024Acuta Capital Partners LLC25,100$1.39M1.1%N/A0.027%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets28,831$1.60M0.0%-57.3%0.031%Search for SEC Filing on Google Icon
11/13/2024FMR LLC637,821$35.43M0.0%-1.5%0.691%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 238,055$13.22M0.0%-3.7%0.258%Search for SEC Filing on Google Icon
11/12/2024Pitcairn Co.10,584$0.59M0.0%-12.1%0.011%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC73,902$4.11M0.1%+46.9%0.080%Search for SEC Filing on Google Icon
11/12/2024Cerity Partners LLC31,919$1.77M0.0%N/A0.035%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.594,521$33.03M0.0%+10.6%0.644%Search for SEC Filing on Google Icon
11/12/2024Massachusetts Financial Services Co. MA542,373$30.13M0.0%+46.5%0.587%Search for SEC Filing on Google Icon
11/8/2024BNP PARIBAS ASSET MANAGEMENT Holding S.A.724,182$40.23M0.1%-12.8%0.786%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.75,265$4.18M0.0%-53.8%0.082%Search for SEC Filing on Google Icon
11/8/2024B. Metzler seel. Sohn & Co. Holding AG23,817$1.32M0.0%N/A0.026%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC2,145$0.12M0.0%N/A0.002%Search for SEC Filing on Google Icon
11/7/2024Swiss National Bank159,152$8.84M0.0%+9.1%0.173%Search for SEC Filing on Google Icon
11/6/2024Mutual of America Capital Management LLC5,780$0.32M0.0%N/A0.006%Search for SEC Filing on Google Icon
11/6/2024Natixis Advisors LLC52,562$2.92M0.0%+290.0%0.057%Search for SEC Filing on Google Icon
11/6/2024KBC Group NV2,568$0.14M0.0%+24.5%0.003%Search for SEC Filing on Google Icon
11/6/2024Pier 88 Investment Partners LLC22,540$1.25M0.3%-13.2%0.024%Search for SEC Filing on Google Icon
11/6/2024Angeles Investment Advisors LLC5,911$0.33M0.0%-11.0%0.006%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.10,948$0.61M0.0%+8.8%0.012%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP11,508$0.64M0.0%-26.1%0.012%Search for SEC Filing on Google Icon
11/5/2024WCM Investment Management LLC145,349$7.91M0.0%-6.0%0.158%Search for SEC Filing on Google Icon
11/4/2024State of New Jersey Common Pension Fund D34,769$1.93M0.0%-28.7%0.038%Search for SEC Filing on Google Icon
11/2/2024Privium Fund Management B.V.242,512$13.47M3.4%-3.6%0.263%Search for SEC Filing on Google Icon
11/1/2024Atria Investments Inc4,836$0.27M0.0%N/A0.005%Search for SEC Filing on Google Icon
11/1/2024Capital Performance Advisors LLP1,934$0.11M0.0%N/A0.002%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.86,440$4.80M0.0%+740.0%0.104%Search for SEC Filing on Google Icon
10/29/2024Emerald Advisers LLC569,798$31.65M1.2%+17.1%0.685%Search for SEC Filing on Google Icon
10/29/2024Van ECK Associates Corp1,487$81K0.0%-23.5%0.002%Search for SEC Filing on Google Icon
10/29/2024Emerald Mutual Fund Advisers Trust429,302$23.85M1.2%+9.9%0.516%Search for SEC Filing on Google Icon
10/28/2024Oak Ridge Investments LLC18,622$1.03M0.1%-3.8%0.022%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE4,149$0.23M0.0%-41.3%0.005%Search for SEC Filing on Google Icon
10/25/2024Pinnacle Associates Ltd.119,360$6.63M0.1%-25.9%0.144%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.17,726$0.99M0.1%+81.5%0.021%Search for SEC Filing on Google Icon
10/25/2024abrdn plc253,304$14.07M0.0%-11.0%0.305%Search for SEC Filing on Google Icon
10/25/2024Pallas Capital Advisors LLC10,904$0.60M0.0%N/A0.013%Search for SEC Filing on Google Icon
10/24/2024Wealth Enhancement Advisory Services LLC21,753$1.21M0.0%+195.6%0.024%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.3,333$0.18M0.0%+34.3%0.004%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.1,010$56K0.0%N/A0.001%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.145,433$8.08M0.0%+2.3%0.158%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.78,095$4.34M0.2%+6.6%0.085%Search for SEC Filing on Google Icon
10/22/2024International Assets Investment Management LLC10,388$0.58M0.0%+29,580.0%0.011%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC2,287$0.13M0.0%-31.3%0.002%Search for SEC Filing on Google Icon
10/16/2024nVerses Capital LLC2,700$0.15M0.1%+237.5%0.003%Search for SEC Filing on Google Icon
10/8/2024CWM LLC21,332$1.19M0.0%+9,552.5%0.026%Search for SEC Filing on Google Icon
10/5/2024Handelsbanken Fonder AB24,523$1.36M0.0%+15.0%0.029%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC12,313$0.68M0.0%-22.6%0.013%Search for SEC Filing on Google Icon
9/16/2024Point72 DIFC Ltd2,669$0.11M0.0%-73.4%0.003%Search for SEC Filing on Google Icon
8/29/2024Maven Securities LTD20,000$0.82M0.0%+100.0%0.024%Search for SEC Filing on Google Icon
8/27/2024Clearbridge Investments LLC2,353,804$96.74M0.1%-2.0%2.831%Search for SEC Filing on Google Icon
8/21/2024Truist Financial Corp9,791$0.40M0.0%-3.2%0.012%Search for SEC Filing on Google Icon
8/16/2024Clearline Capital LP32,961$1.36M0.0%N/A0.036%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC50,322$2.07M0.1%+104.8%0.055%Search for SEC Filing on Google Icon
8/16/2024Frazier Life Sciences Management L.P.425,000$17.47M0.8%N/A0.461%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC528,180$21.71M0.2%+35.7%0.573%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Portfolio Strategies LLC7,147$0.29M0.0%-70.4%0.008%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company247,138$10.16M0.0%-14.0%0.268%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC1,850,734$76.07M0.0%+103.8%2.008%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC97,100$3.99M0.0%-61.3%0.105%Search for SEC Filing on Google Icon
8/15/2024AXA S.A.425,334$17.48M0.1%+27.8%0.461%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ultragenyx Pharmaceutical logo
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Japan, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc.; Solid Biosciences Inc.; Regeneron; Abeona; and Daiichi Sankyo Co., Ltd. The company was incorporated in 2010 and is headquartered in Novato, California.
Read More on Ultragenyx Pharmaceutical

Today's Range

Now: $47.24
Low: $45.47
High: $47.47

50 Day Range

MA: $53.14
Low: $43.78
High: $59.36

52 Week Range

Now: $47.24
Low: $37.02
High: $60.37

Volume

593,872 shs

Average Volume

978,390 shs

Market Capitalization

$4.36 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.58

Who are the company insiders with the largest holdings of Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical's top insider shareholders include:
  1. Emil D Kakkis (CEO)
  2. Thomas Richard Kassberg (EVP)
  3. Howard Horn (CFO)
  4. John Richard Pinion (Insider)
  5. Dennis Karl Huang (Insider)
  6. Karah Herdman Parschauer (EVP)
  7. Erik Harris (EVP)
  8. Eric Crombez (EVP)
  9. Camille L Bedrosian (EVP)
  10. Theodore Alan Huizenga (CAO)
  11. Matthew K Fust (Director)
  12. Corazon (Corsee) D Sanders (Director)
Learn More about top insider investors at Ultragenyx Pharmaceutical.

Who are the major institutional investors of Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical's top institutional investors include:
  1. Wellington Management Group LLP — 4.51%
  2. Alkeon Capital Management LLC — 3.26%
  3. State Street Corp — 2.89%
  4. RTW Investments LP — 2.13%
  5. Baker BROS. Advisors LP — 1.71%
  6. Geode Capital Management LLC — 1.70%
Learn More about top institutional investors of Ultragenyx Pharmaceutical stock.

Which major investors are selling Ultragenyx Pharmaceutical stock?

During the last quarter, RARE stock was sold by these institutional investors:
  1. RTW Investments LP
  2. Vestal Point Capital LP
  3. Suvretta Capital Management LLC
  4. Jacobs Levy Equity Management Inc.
  5. Wellington Management Group LLP
  6. Barclays PLC
  7. Cinctive Capital Management LP
  8. BNP PARIBAS ASSET MANAGEMENT Holding S.A.
During the previous year, company insiders that have sold Ultragenyx Pharmaceutical company stock include:
  1. Emil D Kakkis (CEO)
  2. Thomas Richard Kassberg (EVP)
  3. Howard Horn (CFO)
  4. John Richard Pinion (Insider)
  5. Dennis Karl Huang (Insider)
  6. Karah Herdman Parschauer (EVP)
  7. Erik Harris (EVP)
  8. Eric Crombez (EVP)
  9. Camille L Bedrosian (EVP)
Learn More investors selling Ultragenyx Pharmaceutical stock.

Which major investors are buying Ultragenyx Pharmaceutical stock?

During the last quarter, RARE stock was purchased by institutional investors including:
  1. Alkeon Capital Management LLC
  2. Two Sigma Advisers LP
  3. Frazier Life Sciences Management L.P.
  4. Ikarian Capital LLC
  5. Point72 Asset Management L.P.
  6. Massachusetts Financial Services Co. MA
  7. Baker BROS. Advisors LP
  8. Emerald Advisers LLC
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.